Tapewire

Nasdaq · USD

ORMP

ORAMED PHARMACEUTICALS INC.

Export transactions ↓
Tapewire entity
6311
SEC CIK
0001176309
Parsed reports
201

Last 12 months

Inside the activity.

0 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202602
Aug 202600
Sep 202600
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 04, 2024 Filed Jan 8, 2024 21:39 UTC
Silberman DavidChief Financial Officer
GrantCommon Stock 136,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-001146 · doc4.xml · nonDerivative · entry 1

Silberman David · CIK 0001867998 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 366,500

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 11,375 over a three year period starting January 8, 2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 04, 2024 Filed Jan 8, 2024 21:37 UTC
Sank LeonardDirector
GrantCommon Stock 9,325 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-001143 · doc4.xml · nonDerivative · entry 2

Sank Leonard · CIK 0001416089 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,021

F2 · price: Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 2,331 on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 04, 2024 Filed Jan 8, 2024 21:37 UTC
Sank LeonardDirector
GrantCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-001143 · doc4.xml · nonDerivative · entry 1

Sank Leonard · CIK 0001416089 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,696

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2025, January 1, 2026 and January 1, 2027. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 04, 2024 Filed Jan 8, 2024 21:36 UTC
Rozov YadinDirector
GrantCommon Stock 8,820 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-001141 · doc4.xml · nonDerivative · entry 2

Rozov Yadin · CIK 0001921268 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,320

F2 · price: Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of 2,205 on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 04, 2024 Filed Jan 8, 2024 21:36 UTC
Rozov YadinDirector
GrantCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-001141 · doc4.xml · nonDerivative · entry 1

Rozov Yadin · CIK 0001921268 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,500

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2025, January 1, 2026 and January 1, 2027. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 04, 2024 Filed Jan 8, 2024 21:34 UTC
Mayer ArieDirector
GrantCommon Stock 9,325 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-001137 · doc4.xml · nonDerivative · entry 2

Mayer Arie · CIK 0001796583 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,134

F2 · price: Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 2,331 on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 04, 2024 Filed Jan 8, 2024 21:34 UTC
Mayer ArieDirector
GrantCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-001137 · doc4.xml · nonDerivative · entry 1

Mayer Arie · CIK 0001796583 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,809

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2025, January 1, 2026 and January 1, 2027. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 04, 2024 Filed Jan 8, 2024 21:33 UTC GrantCommon Stock 5,070 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-001135 · doc4.xml · nonDerivative · entry 2

Aghion Daniel · CIK 0002004805 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,070

F2 · price: Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 1,267 on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 04, 2024 Filed Jan 8, 2024 21:33 UTC GrantCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-001135 · doc4.xml · nonDerivative · entry 1

Aghion Daniel · CIK 0002004805 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2025, January 1, 2026 and January 1, 2027. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 04, 2024 Filed Jan 8, 2024 21:32 UTC GrantCommon Stock 5,070 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-001131 · doc4.xml · nonDerivative · entry 2

Shapiro Benjamin · CIK 0001974846 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,070

F2 · price: Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 1,267 on April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
January 04, 2024 Filed Jan 8, 2024 21:32 UTC GrantCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-24-001131 · doc4.xml · nonDerivative · entry 1

Shapiro Benjamin · CIK 0001974846 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2025, January 1, 2026 and January 1, 2027. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
May 26, 2023 Filed May 31, 2023 21:10 UTC
KIDRON NADAVDirector · President and CEO
GrantCommon Stock 120,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-033145 · doc4.xml · nonDerivative · entry 1

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,452,098

F1 · price: Restricted Stock Units ("RSUs") granted in April 2023 and vested upon achievement of certain performance conditions. The RSUs converted into Issuer's common stock on a one-for-one basis.

Read SEC document
May 26, 2023 Filed May 31, 2023 21:10 UTC
Kidron MiriamDirector · Chief Scientific Officer
GrantCommon Stock 53,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-033143 · doc4.xml · nonDerivative · entry 1

Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 468,166

F1 · price: Restricted Stock Units ("RSUs") granted in April 2023 and vested upon achievement of certain performance conditions. The RSUs converted into Issuer's common stock on a one-for-one basis.

Read SEC document
May 26, 2023 Filed May 31, 2023 21:10 UTC
Derovan NetanelChief Legal Officer
GrantCommon Stock 20,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-033144 · doc4.xml · nonDerivative · entry 1

Derovan Netanel · CIK 0001901330 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 149,500

F1 · price: Restricted Stock Units ("RSUs") granted in April 2023 and vested upon achievement of certain performance conditions. The RSUs converted into Issuer's common stock on a one-for-one basis.

Read SEC document
May 26, 2023 Filed May 31, 2023 21:10 UTC
Hexter JoshuaCOO & CBO
GrantCommon Stock 27,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-033142 · doc4.xml · nonDerivative · entry 1

Hexter Joshua · CIK 0001573235 · COO & CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 301,333

F1 · price: Restricted Stock Units ("RSUs") granted in April 2023 and vested upon achievement of certain performance conditions. The RSUs converted into Issuer's common stock on a one-for-one basis.

Read SEC document
May 26, 2023 Filed May 31, 2023 21:10 UTC
Silberman DavidChief Financial Officer
GrantCommon Stock 24,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-033141 · doc4.xml · nonDerivative · entry 1

Silberman David · CIK 0001867998 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 230,000

F1 · price: Restricted Stock Units ("RSUs") granted in April 2023 and vested upon achievement of certain performance conditions. The RSUs converted into Issuer's common stock on a one-for-one basis.

Read SEC document
May 01, 2023 Filed May 1, 2023 21:12 UTC GrantCommon Stock 20,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-026306 · doc4.xml · nonDerivative · entry 1

Shapiro Benjamin · CIK 0001974846 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 1,666 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
April 17, 2023 Filed Apr 20, 2023 10:00 UTC
Sank LeonardDirector
GrantCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-024942 · doc4.xml · nonDerivative · entry 1

Sank Leonard · CIK 0001416089 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,696

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 2,500 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
April 17, 2023 Filed Apr 20, 2023 10:00 UTC
Derovan NetanelChief Legal Officer
GrantCommon Stock 81,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-024941 · doc4.xml · nonDerivative · entry 1

Derovan Netanel · CIK 0001901330 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,000

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 6,750 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
April 17, 2023 Filed Apr 20, 2023 10:00 UTC
Hexter JoshuaCOO & CBO
GrantCommon Stock 108,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-024940 · doc4.xml · nonDerivative · entry 1

Hexter Joshua · CIK 0001573235 · COO & CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 274,333

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 9,000 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
April 17, 2023 Filed Apr 20, 2023 10:00 UTC
KIDRON NADAVDirector · President and CEO
GrantCommon Stock 279,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-024939 · doc4.xml · nonDerivative · entry 1

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,332,098

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 23,250 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
April 17, 2023 Filed Apr 20, 2023 10:00 UTC
Rozov YadinDirector
GrantCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-024938 · doc4.xml · nonDerivative · entry 1

Rozov Yadin · CIK 0001921268 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,500

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 2,500 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
April 17, 2023 Filed Apr 20, 2023 10:00 UTC
Kidron MiriamDirector · Chief Scientific Officer
GrantCommon Stock 213,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-024937 · doc4.xml · nonDerivative · entry 1

Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 414,666

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 17,750 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
April 17, 2023 Filed Apr 20, 2023 10:00 UTC
Silberman DavidChief Financial Officer
GrantCommon Stock 97,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-024936 · doc4.xml · nonDerivative · entry 1

Silberman David · CIK 0001867998 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 205,500

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 8,125 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
April 17, 2023 Filed Apr 20, 2023 10:00 UTC
Mayer ArieDirector
GrantCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-024935 · doc4.xml · nonDerivative · entry 1

Mayer Arie · CIK 0001796583 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,809

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 2,500 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
April 04, 2023 Filed Apr 4, 2023 21:10 UTC
Mayer ArieDirector
PurchaseCommon Stock 3,800 $2.21 $8,398.00
Disclosure

SEC source: 0001209191-23-022815 · doc4.xml · nonDerivative · entry 2

Mayer Arie · CIK 0001796583 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,809

Read SEC document
April 03, 2023 Filed Apr 4, 2023 21:10 UTC
Mayer ArieDirector
PurchaseCommon Stock 5,009 $2.22 $11,119.98
Disclosure

SEC source: 0001209191-23-022815 · doc4.xml · nonDerivative · entry 1

Mayer Arie · CIK 0001796583 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,009

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.17 to $2.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range.

Read SEC document
March 16, 2023 Filed Mar 16, 2023 21:10 UTC
KIDRON NADAVDirector · President and CEO
PurchaseCommon Stock 26,000 $2.04 $53,014.00
Disclosure

SEC source: 0001209191-23-019367 · doc4.xml · nonDerivative · entry 1

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By wholly-owned corporation

Disclosed balance after: 126,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.02 to $2.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range.

Read SEC document
March 14, 2023 Filed Mar 15, 2023 21:25 UTC
KIDRON NADAVDirector · President and CEO
PurchaseCommon Stock 100,000 $2.01 $201,000.00
Disclosure

SEC source: 0001209191-23-018956 · doc4.xml · nonDerivative · entry 1

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By wholly-owned corporation

Disclosed balance after: 100,000

Read SEC document
March 14, 2023 Filed Mar 15, 2023 21:20 UTC
Kidron MiriamDirector · Chief Scientific Officer
SaleCommon Stock 100,000 $2.01 $201,000.00
Disclosure

SEC source: 0001209191-23-018952 · doc4.xml · nonDerivative · entry 1

Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,666

F1 · price: These shares were sold to a company owned solely by Nadav Kidron, a director and the president and chief executive officer of the Issuer, and the Reporting Person used the proceeds in connection with a personal tax payment.

Read SEC document
March 14, 2023 Filed Mar 15, 2023 21:15 UTC
Rozov YadinDirector
PurchaseCommon Stock 50,000 $2.05 $102,450.00
Disclosure

SEC source: 0001209191-23-018944 · doc4.xml · nonDerivative · entry 2

Rozov Yadin · CIK 0001921268 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,500

F2 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range.

Read SEC document
March 13, 2023 Filed Mar 15, 2023 21:15 UTC
Rozov YadinDirector
PurchaseCommon Stock 20,000 $1.96 $39,120.00
Disclosure

SEC source: 0001209191-23-018944 · doc4.xml · nonDerivative · entry 1

Rozov Yadin · CIK 0001921268 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,500

F1 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.95 to $1.96, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 12:24 UTC
Rabinowitz MichaelChief Commercial Officer
SaleCommon Stock 11,900 $12.49 $148,651.23
Disclosure

SEC source: 0001209191-23-000517 · doc4.xml · nonDerivative · entry 2

Rabinowitz Michael · CIK 0001876182 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,143

F1 · date: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 7, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.01 to $13.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 12:24 UTC
Rabinowitz MichaelChief Commercial Officer
SaleCommon Stock 1,425 $13.01 $18,543.81
Disclosure

SEC source: 0001209191-23-000517 · doc4.xml · nonDerivative · entry 1

Rabinowitz Michael · CIK 0001876182 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,043

F1 · date: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 7, 2022.

Read SEC document
October 27, 2022 Filed Oct 29, 2022 01:30 UTC
KIDRON NADAVDirector · President and CEO
GiftCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-054879 · doc4.xml · nonDerivative · entry 1

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,053,098

F1 · price: This transaction represents a charitable donation effective October 27, 2022. This is not a market transaction, thus no price has been reported. No value was received for the donated shares.

Read SEC document
August 08, 2022 Filed Aug 10, 2022 20:30 UTC
Sank LeonardDirector
Exercise / conversionStock Option · Derivative 20,000 $0.00 Strike: $4.08 $0.00
Disclosure

SEC source: 0001209191-22-045207 · doc4.xml · derivative · entry 3

Sank Leonard · CIK 0001416089 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2022-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The options vested as follows: 10,000 vested on each of January 1, 2013 and 2014.

Read SEC document
August 08, 2022 Filed Aug 10, 2022 20:30 UTC
Sank LeonardDirector
Tax withholdingCommon Stock 9,304 $8.77 $81,596.08
Disclosure

SEC source: 0001209191-22-045207 · doc4.xml · nonDerivative · entry 2

Sank Leonard · CIK 0001416089 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,696

F1 · shares: Represents a cashless exercise of outstanding stock options to purchase 20,000 shares of common stock. The reporting person received 10,696 shares of common stock and surrendered 9,304 shares of common stock underlying the stock option in payment of the exercise price.

Read SEC document
August 08, 2022 Filed Aug 10, 2022 20:30 UTC
Sank LeonardDirector
Exercise / conversionCommon Stock 20,000 $4.08 $81,600.00
Disclosure

SEC source: 0001209191-22-045207 · doc4.xml · nonDerivative · entry 1

Sank Leonard · CIK 0001416089 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 01, 2022 Filed Aug 2, 2022 00:00 UTC
KIDRON NADAVDirector · President and CEO
Tax withholdingCommon Stock 12,631 $8.36 $105,595.16
Disclosure

SEC source: 0001209191-22-043768 · doc4.xml · nonDerivative · entry 3

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,078,098

F3 · shares: Payment of tax liability by withholding securities related to the 34,000 shares of Common Stock granted on July 28, 2022.

Read SEC document
July 28, 2022 Filed Aug 2, 2022 00:01 UTC
Rozov YadinDirector
GrantCommon Stock 12,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-043772 · doc4.xml · nonDerivative · entry 1

Rozov Yadin · CIK 0001921268 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,500

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 4,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
July 28, 2022 Filed Aug 2, 2022 00:00 UTC
Derovan NetanelChief Legal Officer
GrantCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-043770 · doc4.xml · nonDerivative · entry 1

Derovan Netanel · CIK 0001901330 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,000

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
July 28, 2022 Filed Aug 2, 2022 00:01 UTC
Mayer ArieDirector
GrantCommon Stock 12,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-043771 · doc4.xml · nonDerivative · entry 1

Mayer Arie · CIK 0001796583 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 4,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
July 28, 2022 Filed Aug 2, 2022 00:00 UTC
Kidron MiriamDirector · Chief Scientific Officer
GrantCommon Stock 84,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-043769 · doc4.xml · nonDerivative · entry 2

Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 301,666

F2 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 28,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
July 28, 2022 Filed Aug 2, 2022 00:00 UTC
Kidron MiriamDirector · Chief Scientific Officer
GrantCommon Stock 34,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-043769 · doc4.xml · nonDerivative · entry 1

Kidron Miriam · CIK 0001409232 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,666

F1 · price: Represents Common Stock granted by the Issuer that vested on August 1, 2022.

Read SEC document
July 28, 2022 Filed Aug 2, 2022 00:00 UTC
Hexter JoshuaCOO & CBO
GrantCommon Stock 42,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-043767 · doc4.xml · nonDerivative · entry 1

Hexter Joshua · CIK 0001573235 · COO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,333

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 14,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
July 28, 2022 Filed Aug 2, 2022 00:00 UTC
KIDRON NADAVDirector · President and CEO
GrantCommon Stock 126,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-043768 · doc4.xml · nonDerivative · entry 2

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,090,729

F2 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 42,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
July 28, 2022 Filed Aug 2, 2022 00:00 UTC
KIDRON NADAVDirector · President and CEO
GrantCommon Stock 34,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-043768 · doc4.xml · nonDerivative · entry 1

KIDRON NADAV · CIK 0001351779 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 964,729

F1 · price: Represents Common Stock granted by the Issuer that vested on August 1, 2022.

Read SEC document
July 28, 2022 Filed Aug 2, 2022 00:00 UTC
Sank LeonardDirector
GrantCommon Stock 12,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-043766 · doc4.xml · nonDerivative · entry 1

Sank Leonard · CIK 0001416089 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 4,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

F2 · balance_after: The reporting person previously reported and disclaimed beneficial ownership over 138,889 shares of common stock owned by a company wholly owned by a trust of which the reporting person was previously a trustee. The reporting person resigned as a trustee of such trust, effective February 3, 2022.

Read SEC document
July 28, 2022 Filed Aug 2, 2022 00:00 UTC
Rabinowitz MichaelChief Commercial Officer
GrantCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-043764 · doc4.xml · nonDerivative · entry 1

Rabinowitz Michael · CIK 0001876182 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 139,468

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 10,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document
July 28, 2022 Filed Aug 2, 2022 00:00 UTC
Silberman DavidChief Financial Officer
GrantCommon Stock 39,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-043765 · doc4.xml · nonDerivative · entry 1

Silberman David · CIK 0001867998 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,000

F1 · price: Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 13,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.